Join to View Full Profile
351 North Sumneytown PikeMerck & Co IncGwynedd, PA 19454
Dr. Barr is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1986
Johns Hopkins UniversityFellowship, Cardiovascular Disease
MedStar Health Georgetown University (Baltimore)Residency, Internal Medicine
Certifications & Licensure
PA State Medical License 1995 - 2018
Publications & Presentations
PubMed
- 2 citationsEfficacy and Safety of Elbasvir/Grazoprevir in Hepatitis C Virus GT1- and GT4-Infected People Aged 65 Years or Older.Steven L. Flamm, Cheng Yuan Peng, Oren Shibolet, Ronald Nahass, Peggy Hwang
Gerontology & Geriatric Medicine. 2019-01-22 - 19 citationsElbasvir/grazoprevir and sofosbuvir for hepatitis C virus genotype 3 infection with compensated cirrhosis: A randomized trial.Graham R. Foster, Kosh Agarwal, Matthew E. Cramp, Sulleman Moreea, Stephen T. Barclay
Hepatology. 2018-06-01 - 24 citationsEfficacy and safety of 12 weeks of elbasvir ± grazoprevir ± ribavirin in participants with hepatitis C virus genotype 2, 4, 5 or 6 infection: The C-SCAPE studyAshley Brown, Christophe Hézode, Eli Zuckerman, Graham R. Foster, Amany Zekry
Journal of Viral Hepatitis. 2018-05-01
Press Mentions
In What Could Be a 'Big Shift' for Cancer Treatment, mRNA Vaccine Shows Promise Against MelanomaApril 16th, 2023- Merck Gets USFDA Nod for Keytruda in Combination with Padcev to Treat Advanced or Metastatic Urothelial CancerApril 4th, 2023
- Keytruda plus Chemotherapy Reduce Risk of Endometrial CancerMarch 28th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
